SP
Sarasin & Partners’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $104M | Sell |
256,589
-119,485
| -32% | -$48.4M | 1.04% | 33 |
|
|
2025
Q1 | $187M | Buy |
+376,074
| New | +$187M | 2.03% | 23 |
|
|
2024
Q4 | – | Sell |
-488,325
| Closed | -$302M | – | 74 |
|
|
2024
Q3 | $302M | Sell |
488,325
-71,851
| -13% | -$44.4M | 2.85% | 17 |
|
|
2024
Q2 | $310M | Buy |
560,176
+100,383
| +22% | +$55.5M | 2.74% | 15 |
|
|
2024
Q1 | $267M | Buy |
459,793
+43,678
| +10% | +$25.4M | 2.63% | 15 |
|
|
2023
Q4 | $221M | Buy |
416,115
+50,372
| +14% | +$26.7M | 2.43% | 15 |
|
|
2023
Q3 | $185M | Buy |
365,743
+8,570
| +2% | +$4.34M | 2.31% | 17 |
|
|
2023
Q2 | $186M | Buy |
357,173
+114,497
| +47% | +$59.7M | 2.16% | 18 |
|
|
2023
Q1 | $140M | Sell |
242,676
-64,547
| -21% | -$37.2M | 0.75% | 43 |
|
|
2022
Q4 | $169M | Buy |
307,223
+29,865
| +11% | +$16.4M | 2.22% | 17 |
|
|
2022
Q3 | $141M | Buy |
277,358
+16,490
| +6% | +$8.36M | 1.95% | 19 |
|
|
2022
Q2 | $142M | Buy |
260,868
+125,631
| +93% | +$68.3M | 1.79% | 23 |
|
|
2022
Q1 | $79.9M | Buy |
+135,237
| New | +$79.9M | 0.8% | 39 |
|